MedTrace Logo

Implementation of Teledermoscopy and Artificial Intelligence

NCT05033678 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 8000

Last updated 2025-07-16

No results posted yet for this study

Summary

The study has 2 parts. Part 1 will investigate the effects of introducing teledermoscopy in clinical practice, more specifically the change in referral patterns, the risk of undetected skin cancers and the effect on diagnostic accuracy in general practitioners.

Part 2 will investigate how to introduce artificial intelligence (AI) within teledermocsopy. In this study the investigators will measure the diagnostic accuracy of teledermoscopic assessors that had access to the results of artificial intelligence algorithm compared to those who did not.

Data will be collected through teledermoscopic referrals, patient records, national registries and questionnairs.

Conditions

Interventions

DEVICE

Diagnostic algorithms

Assessors of teledermoscopy will be randomly assigned to use the results of artificial intelligence when the assess a teledermoscopic case.

Sponsors & Collaborators

  • Lund University

    collaborator OTHER

  • Karolinska University Hospital

    collaborator OTHER

  • Region Skane

    lead OTHER

Principal Investigators

  • Asa Ingvar, PhD · Department of Dermatology, Skane University Hospital, Region Skane, Sweden

Eligibility

Min Age
15 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-08-16
Primary Completion
2029-08-31
Completion
2029-08-31

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05033678 on ClinicalTrials.gov